| Rehabilitation And Nursing Center Of The Rockies | |
| 1020 Patton St, Fort Collins, Colorado 80524 | |
| (970) 484-7981 | |
| Name | Rehabilitation And Nursing Center Of The Rockies |
|---|---|
| Location | 1020 Patton St, Fort Collins, Colorado |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 96 |
| Occupancy Rate | 58.44% |
| Medicare ID (CCN) | 065192 |
| Legal Business Name | Hanlon Bush Investments, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1023643806 |
| Organization Name | CASTLE PINES HEALTHCARE LLC |
| Address | 1020 Patton St, Fort Collins, CO 80524 |
| Phone Number | 970-484-7981 |
News Archive
A two-year study led by researchers at Ben-Gurion University of the Negev (BGU) found that healthy, long-term weight loss diets can significantly reverse carotid (main brain artery) atherosclerosis, a direct risk factor for strokes and heart attacks. The study is one of the first to prove the potential of moderate weight loss as a strategy to reverse atherosclerosis (hardening of the arteries) in overweight and mildly obese people.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
Scientists on the Florida campus of The Scripps Research Institute have designed a compound that shows promise as a potential therapy for one of the diseases closely linked to fragile X syndrome, a genetic condition that causes mental retardation, infertility, and memory impairment, and is the only known single-gene cause of autism.
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.
Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.
› Verified 8 days ago
| NPI Number | 1982799383 |
| Organization Name | HANLON-BUSH INVESTMENTS, LLC |
| Doing Business As | REHABILITATION AND NURSING CENTER OF THE ROCKIES |
| Address | 1020 Patton Street, Fort Collins, CO 80524 |
| Phone Number | 970-484-7981 |
News Archive
A two-year study led by researchers at Ben-Gurion University of the Negev (BGU) found that healthy, long-term weight loss diets can significantly reverse carotid (main brain artery) atherosclerosis, a direct risk factor for strokes and heart attacks. The study is one of the first to prove the potential of moderate weight loss as a strategy to reverse atherosclerosis (hardening of the arteries) in overweight and mildly obese people.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
Scientists on the Florida campus of The Scripps Research Institute have designed a compound that shows promise as a potential therapy for one of the diseases closely linked to fragile X syndrome, a genetic condition that causes mental retardation, infertility, and memory impairment, and is the only known single-gene cause of autism.
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.
Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.
› Verified 8 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
A two-year study led by researchers at Ben-Gurion University of the Negev (BGU) found that healthy, long-term weight loss diets can significantly reverse carotid (main brain artery) atherosclerosis, a direct risk factor for strokes and heart attacks. The study is one of the first to prove the potential of moderate weight loss as a strategy to reverse atherosclerosis (hardening of the arteries) in overweight and mildly obese people.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
Scientists on the Florida campus of The Scripps Research Institute have designed a compound that shows promise as a potential therapy for one of the diseases closely linked to fragile X syndrome, a genetic condition that causes mental retardation, infertility, and memory impairment, and is the only known single-gene cause of autism.
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.
Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.
› Verified 8 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $195615 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 9.45 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 1.99 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 32 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 0.43 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.46 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 6.1 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 3.1 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 93.36 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 18.1 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 47.13 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 0 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 15.58 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 11.32 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 6.02 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 92.22 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 92.95 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 10.89 | 82.93 |
News Archive
A two-year study led by researchers at Ben-Gurion University of the Negev (BGU) found that healthy, long-term weight loss diets can significantly reverse carotid (main brain artery) atherosclerosis, a direct risk factor for strokes and heart attacks. The study is one of the first to prove the potential of moderate weight loss as a strategy to reverse atherosclerosis (hardening of the arteries) in overweight and mildly obese people.
Asuragen Inc., a leading molecular biology diagnostic company and service provider, today announced an agreement to develop and manufacture RNA Control Kits for Affymetrix. The RNA Control Kit is intended for use with in vitro transcription (IVT) reagent kits for clinical molecular diagnostic applications that Asuragen has licensed and supplied to Affymetrix.
Scientists on the Florida campus of The Scripps Research Institute have designed a compound that shows promise as a potential therapy for one of the diseases closely linked to fragile X syndrome, a genetic condition that causes mental retardation, infertility, and memory impairment, and is the only known single-gene cause of autism.
Researchers have discovered a link between prostate cancer aggressiveness and the accumulation of a compound produced when cholesterol is metabolized in cells, findings that could bring new diagnostic and treatment methods.
Young Innovations, Inc. today announced the completion of its acquisition by affiliates of Linden Capital Partners in an all-cash transaction valued at approximately $314 million.
› Verified 8 days ago
Lemay Avenue Health And Rehabilitation Facility Location: 4824 S Lemay Ave, Fort Collins, Colorado 80525 Phone: (970) 482-1584 | |
Fort Collins Health Care Center Location: 1000 S Lemay Ave, Fort Collins, Colorado 80524 Phone: (970) 482-7925 | |
Rehabilitation And Nursing Center Of The Rockies Location: 1020 Patton St, Fort Collins, Colorado 80524 Phone: (970) 484-7981 | |
Spring Creek Health Care Center Location: 1000 E Stuart St, Fort Collins, Colorado 80525 Phone: (970) 482-5712 | |
Good Samaritan Society - Fort Collins Village Location: 508 W Trilby Rd, Fort Collins, Colorado 80525 Phone: (970) 226-4909 | |
Columbine West Health And Rehab Facility Location: 940 Worthington Cir, Fort Collins, Colorado 80526 Phone: (970) 221-2273 |